We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$302M
AUM Growth
+$30.4M
Cap. Flow
+$11M
Cap. Flow %
3.65%
Top 10 Hldgs %
28.21%
Holding
204
New
14
Increased
71
Reduced
33
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 20.54%
2 Technology 14.44%
3 Consumer Discretionary 8.64%
4 Communication Services 7.66%
5 Financials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMAT icon
176
LeMaitre Vascular
LMAT
$1.89B
$244K 0.08%
+4,000
New +$212K
VYM icon
177
Vanguard High Dividend Yield ETF
VYM
$83.8B
$237K 0.08%
2,262
-19
-0.8% -$2K
DNLI icon
178
Denali Therapeutics
DNLI
$3.95B
$235K 0.08%
+3,000
New +$186K
VB icon
179
Vanguard Morningstar Small-Cap ETF
VB
$82.8B
$234K 0.08%
1,040
-50
-5% -$11.1K
MDYG icon
180
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
$233K 0.08%
3,006
-69
-2% -$5.31K
JPM icon
181
JPMorgan Chase
JPM
$962B
$231K 0.08%
+1,483
New +$233K
IWR icon
182
iShares Russell Mid-Cap ETF
IWR
$57.7B
$229K 0.08%
2,884
EWJ icon
183
iShares MSCI Japan ETF
EWJ
$22.7B
$228K 0.08%
3,382
+250
+8% +$17.1K
GLD icon
184
SPDR Gold Trust
GLD
$143B
$228K 0.08%
1,375
CARR icon
185
Carrier Global
CARR
$52.4B
$221K 0.07%
4,552
-499
-10% -$22.3K
INTC icon
186
Intel
INTC
$493B
$221K 0.07%
3,938
+640
+19% +$37.6K
RDY icon
187
Dr. Reddy's Laboratories
RDY
$10.4B
$221K 0.07%
+15,000
New +$210K
LIVN icon
188
LivaNova
LIVN
$4.33B
$219K 0.07%
+2,600
New +$214K
FDIS icon
189
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
$217K 0.07%
2,671
FSLY icon
190
Fastly Inc
FSLY
$4.58B
$215K 0.07%
3,600
RVMD icon
191
Revolution Medicines
RVMD
$44.1B
$213K 0.07%
6,725
ELAN icon
192
Elanco Animal Health
ELAN
$11.4B
$208K 0.07%
+6,000
New +$198K
T icon
193
AT&T
T
$168B
$205K 0.07%
+9,423
New +$214K
LIN icon
194
Linde
LIN
$226B
$202K 0.07%
+700
New +$204K
JNCE
195
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$131K 0.04%
19,221
+6,377
+50% +$53K
DHF
196
BNY Mellon High Yield Strategies Fund
DHF
$175M
$95K 0.03%
25,900
VVR icon
197
Invesco Senior Income Trust
VVR
$460M
$80K 0.03%
18,035
AWH
198
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$56K 0.02%
667
YARW
199
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
$38K 0.01%
12
-5
-29% -$19.8K
CWB icon
200
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
-4,778
Closed -$398K

Similar funds

Fernwood Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Fernwood Investment Management held 204 positions worth $302M, up 11% from $272M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Fernwood Investment Management deployed $11M of net new capital in Q2 2021, opening 14 new positions and adding to 71 existing holdings. Its largest new stake was Pliant Therapeutics: 151,111 shares worth $4.41M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $200K trimmed.

  • Fernwood Investment Management's largest Q2 2021 buy was Pliant Therapeutics: 151,111 shares worth $4.41M.
  • Fernwood Investment Management added most to iShares TIPS Bond ETF in Q2 2021, an estimated $904K increase.
  • Fernwood Investment Management's biggest Q2 2021 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $200K.
  • Fernwood Investment Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $1.08M.
  • Fernwood Investment Management's ten largest holdings make up 28% of its $302M portfolio in Q2 2021.
  • Fernwood Investment Management opened 14 new positions and closed 5 in Q2 2021.
  • Fernwood Investment Management's portfolio value rose 11% quarter-over-quarter to $302M.

Based on Fernwood Investment Management's 13F filing for Q2 2021, filed 5 Aug 2021.